BG43867A3 - Method for preparing of 6- alpha- methylcorticoids - Google Patents

Method for preparing of 6- alpha- methylcorticoids

Info

Publication number
BG43867A3
BG43867A3 BG070923A BG7092383A BG43867A3 BG 43867 A3 BG43867 A3 BG 43867A3 BG 070923 A BG070923 A BG 070923A BG 7092383 A BG7092383 A BG 7092383A BG 43867 A3 BG43867 A3 BG 43867A3
Authority
BG
Bulgaria
Prior art keywords
methylcorticoids
alpha
preparing
compounds obtained
pharmacological agents
Prior art date
Application number
BG070923A
Other languages
Bulgarian (bg)
English (en)
Inventor
Klaus Annen
Henry Laurent
Helmut Hofmeister
Rudolf Wiechert
Hans Wendt
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of BG43867A3 publication Critical patent/BG43867A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Detergent Compositions (AREA)
  • Seasonings (AREA)
BG070923A 1982-11-22 1983-11-22 Method for preparing of 6- alpha- methylcorticoids BG43867A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823243482 DE3243482A1 (de) 1982-11-22 1982-11-22 Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
BG43867A3 true BG43867A3 (en) 1988-08-15

Family

ID=6178924

Family Applications (2)

Application Number Title Priority Date Filing Date
BG063156A BG42677A3 (en) 1982-11-22 1983-11-22 Method for preparing of 6- alpha- methylcorticoides
BG070923A BG43867A3 (en) 1982-11-22 1983-11-22 Method for preparing of 6- alpha- methylcorticoids

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG063156A BG42677A3 (en) 1982-11-22 1983-11-22 Method for preparing of 6- alpha- methylcorticoides

Country Status (22)

Country Link
US (1) US4645763A (da)
EP (1) EP0110041B1 (da)
JP (1) JPS59106500A (da)
AT (1) ATE28651T1 (da)
AU (1) AU2098983A (da)
BG (2) BG42677A3 (da)
CA (1) CA1303607C (da)
CS (1) CS248712B2 (da)
DD (1) DD219200A5 (da)
DE (2) DE3243482A1 (da)
DK (1) DK159686C (da)
ES (1) ES8405421A1 (da)
GB (1) GB2130587A (da)
GR (1) GR79725B (da)
HU (1) HU190746B (da)
IE (1) IE56281B1 (da)
IL (1) IL70160A (da)
NO (1) NO157454C (da)
PL (3) PL138796B1 (da)
PT (1) PT77408B (da)
RO (2) RO89343A (da)
ZA (1) ZA838720B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60161914A (ja) * 1984-02-02 1985-08-23 Green Cross Corp:The ステロイド脂肪酸エステル含有直腸投与製剤
JPS61274795A (ja) * 1985-05-30 1986-12-04 Toshiba Corp 曝気槽の溶存酸素濃度制御装置
US4968822A (en) * 1987-12-11 1990-11-06 Taisho Pharmaceutical Co., Ltd. 21-alkoxysteroid compounds
AU7556291A (en) * 1990-03-27 1991-10-21 Schering Corporation Process for 9alpha-hydroxy steroid dehydration
DE4333920A1 (de) * 1993-10-05 1995-04-13 Hoechst Ag Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
ITMI20011762A1 (it) 2001-08-10 2003-02-10 Cosmo Spa Esteri di 17alfa,21-diidrossipregnene, loro uso come agenti anti-androgenetici e procedimenti per la loro preparazione
ITMI20071616A1 (it) 2007-08-03 2009-02-04 Cosmo Spa Processo enzimatico per l'ottenimento di 17-alfa monoesteri del cortexolone e/o suoi 9,11-deidroderivati.
ES2744879T3 (es) * 2008-05-28 2020-02-26 Reveragen Biopharma Inc Moduladores esteroideos no hormonales de NF-kappaB para el tratamiento de enfermedades
WO2011127048A2 (en) 2010-04-05 2011-10-13 Validus Biopharma NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE
EP3108879A1 (en) 2015-06-25 2016-12-28 Cassiopea S.p.A. High concentration formulation
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3053832A (en) * 1957-04-29 1962-09-11 Schering Corp Alkylated cortical steroids
GB921533A (en) * 1958-07-12 1963-03-20 Syntex Sa Cyclopentanophenanthrene derivatives and process for the production thereof
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
DE2645104C2 (de) * 1976-10-04 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen 11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung
US4243586A (en) * 1980-01-18 1981-01-06 E. R. Squibb & Sons, Inc. Steroidal-17-spiro-dihydrofuranones
US4318853A (en) * 1980-01-31 1982-03-09 The Upjohn Company 9β,11β-Epoxy-5β-corticoids
US4336200A (en) * 1980-01-31 1982-06-22 The Upjohn Company 17α-Acyloxy-5β-corticoids
DE3169460D1 (en) * 1980-12-23 1985-04-25 Schering Ag 6-alpha-methyl hydrocortisone derivatives, their preparation and their utilization

Also Published As

Publication number Publication date
ATE28651T1 (de) 1987-08-15
ES526446A0 (es) 1984-06-16
DK533783A (da) 1984-05-23
PL138796B1 (en) 1986-11-29
GB8327736D0 (en) 1983-11-16
DE3243482A1 (de) 1984-05-24
IL70160A (en) 1988-03-31
CA1303607C (en) 1992-06-16
ZA838720B (en) 1984-07-25
CS248712B2 (en) 1987-02-12
BG42677A3 (en) 1988-01-15
IL70160A0 (en) 1984-02-29
RO89343A (ro) 1986-03-15
DE3372776D1 (en) 1987-09-03
DD219200A5 (de) 1985-02-27
DK159686C (da) 1991-04-15
PT77408A (de) 1983-10-01
HU190746B (en) 1986-10-28
PL244685A1 (en) 1985-04-24
PL250735A1 (en) 1985-07-30
US4645763A (en) 1987-02-24
AU2098983A (en) 1984-05-31
PT77408B (de) 1986-02-27
IE832708L (en) 1984-05-22
RO93593B (ro) 1988-01-01
IE56281B1 (en) 1991-06-05
GB2130587A (en) 1984-06-06
NO157454C (no) 1988-03-23
GR79725B (da) 1984-10-31
ES8405421A1 (es) 1984-06-16
PL141686B1 (en) 1987-08-31
RO93593A (ro) 1987-12-31
JPS59106500A (ja) 1984-06-20
DK533783D0 (da) 1983-11-22
DK159686B (da) 1990-11-19
EP0110041A1 (de) 1984-06-13
JPH0415799B2 (da) 1992-03-19
EP0110041B1 (de) 1987-07-29
PL250734A1 (en) 1985-07-30
NO157454B (no) 1987-12-14
NO834265L (no) 1984-05-23

Similar Documents

Publication Publication Date Title
BG32851A3 (en) Method for obtaining of 3, 4, 5, 6- tetrahydro- 2 h- 1- benzoxycin
BG34908A3 (en) Method for preparing d- 6- n- propylergolines
BG35330A3 (en) Method for preparing 3- iodine- methylcephalosporines
BG43867A3 (en) Method for preparing of 6- alpha- methylcorticoids
BG40482A3 (en) Method for preparing phenetanolamines
BG41821A3 (en) Method for preparing pyridyl derivatives
BG41124A3 (en) Method for preparing benzamides
BG35042A3 (en) Method for preparing benzodiazepinic compounds
BG35746A3 (en) Method for preparing 1- cyclohexenylmethylpyrolidines
BG40803A3 (en) Method for preparing arylcyclobutylalkylaminic derivatives
BG38637A3 (en) Method for preparing 2- exo- hydroxy- 7- oxabicyclo [2, 2, 1] heptanes
BG44203A3 (en) Method for preparing of 2- oxyindol- 1- carboxamides
BG34610A3 (en) Method for preparating 2', 6'- dialkyl- n- (alkoxymethyl)- 2- chloracetanylides
IT1145435B (it) Procedimento per la produzione di 2,3-dimetilbutene-2
IT1172398B (it) Procedimento per la produzione di 1,2-diclorcetano
BG35045A3 (en) Method for preparing substituted triarylthiazolic compounds
BG41129A3 (en) Method for preparing acetamide derivatives
BG40809A3 (en) Method for preparing organic chemical compounds
BG35896A3 (en) Method for preparing 3- halogen- 3- cephem compounds
BG30918A3 (en) Method for obtaining of substituated 5h- dibenz ( b, f )- azerine
BG35895A3 (en) Method for preparing of n- substituted- 2- haloacetanilides
IT1155795B (it) Metodo di sintesi per la preparazione della 3,4,5-trimetossibenzaldeide
BG36633A3 (en) Method for preparing 3- hydroxycephalosporines
BG40808A3 (en) Method for preparing derivatives of pyrrolidine
ES8400401A1 (es) "un procedimiento para preparar un 1,4-dialcohilo inferior-3-alcoxicarbonilo inferior-pirrol-2-acetato de alcohilo inferior".